The 5 Minute Urology Consult 3rd Ed.

PROSTATE, ABSCESS

Garjae D. Lavien, MD

Michael J. Naslund, MD

BASICS

DESCRIPTION

• Prostate abscess is an infection of the prostate with focal accumulation of pus within the prostate gland

• Difficult to initially clinically distinguish from acute bacterial prostatitis

• Usually as a result of ineffective antibiotic therapy for acute prostatitis

– Rare in nonhospitalized patients

EPIDEMIOLOGY

Incidence

Decreasing with widespread use of antibiotics

Prevalence

Diagnosed in 0.2% of patients with urologic symptoms, 0.5–2.5% of patients hospitalized for prostatic symptoms (1)

RISK FACTORS

• Bladder outlet obstruction, history of bacterial prostatitis

• Chronic hemodialysis

• Compromised immune system (eg, HIV/AIDS, diabetes, etc.)

• Indwelling catheters

• Lower urinary tract instrumentation

• Sexually transmitted infections

Genetics

N/A

PATHOPHYSIOLOGY

• Usually an ascending infection in association with poor bladder emptying.

• Urethral infection combined with intraprostatic reflux of infected urine causes acute prostatitis.

• Acute prostatitis can, in patients with immunosuppression or other risk factors, progress to abscess.

• Hematogenous dissemination, especially with Staphylococcus sp. seen in immunocompromised patients/IV drug users.

• Most common etiologic agent is Escherichia coli (2)[B].

• With the advent of antibiotics, the incidence of Neisseria gonorrhea as causative agent has decreased significantly.

• Most common etiologic agent seen in emphysematous prostate abscess (EPA) is Klebsiella pneumoniae (3)[B].

• With severe immunocompromise, such as HIV; more unusual organisms such as TB, Cryptococcus, histoplasmosis, and Candida should be considered.

• Melioidosis is an infection (usually abscesses in many sites including the prostate).

– Caused by the gram-negative Burkholderia pseudomallei.

– Usually associated with diabetes.

– Very high prevalence in East Asia and Northern Australia.

ASSOCIATED CONDITIONS

• Any disease process that causes immunocompromise:

– Cancer

– Chronic renal failure, hemodialysis

– Cirrhosis

– Diabetes

– HIV/AIDS

GENERAL PREVENTION

• Aimed at preventing and treating sexually transmitted infections

• Relieving/improving signs/symptoms of bladder outlet obstruction

• Diabetic glycemic control

• Appropriate treatment of patients with acute prostatitis

DIAGNOSIS

HISTORY

• Fevers, chills

• Urinary symptoms with attention paid to voiding patterns prior to acute presentation

– Dysuria, urinary urgency and frequency are almost universal symptoms

– Suprapubic or subpubic pain,

– Severe perineal pain

– Rectal tenesmus

• Acute urinary retention

• Sexual history/social history (IV drug use, etc.)

• Associated medical comorbidities

ALERT

Where prostate abscess or acute prostatitis is suspected, rectal exam may be contraindicated.

PHYSICAL EXAM

• Perineal pain, tenderness

• Urethral discharge

• Digital rectal exam can reveal exquisitely tender and warm prostate with fluctuance or simply an enlarged prostate

• Signs of other medical comorbidities (ie, new cardiac murmur, ascites, cough, track marks, etc.)

DIAGNOSTIC TESTS & INTERPRETATION

Lab

• Complete blood count with differential

• Urinalysis, urine/blood cultures

• Gram stain/culture of prostatic fluid once drained

• AFB or mycobacterium-specific PCR if TB suspected

• Prostate-specific antigen should not be obtained in this setting as it will usually be elevated due to the inflammatory process

Imaging

• Transrectal ultrasound (TRUS)

– Will reveal hypoechoic zones with irregular internal echoes, septations, and indirect borders with the surrounding prostate;

– Must be performed cautiously.

– May guide drainage and aspiration

– The presence of gas suggests EPA

• Color Doppler sonography

– Will show an increase in vascularity around the abscess, due to hyperemia stemming from the surrounding inflammation

• Computed tomography (CT)

– Can determine penetration of the abscess into the periprostatic tissues and identify gas within the prostate

– CT findings include nonenhancing fluid-density collections that can be multiseptated or rim-enhancing lesions.

• MRI

– MRI may not be feasible in patients who are critically ill and require acute management

Diagnostic Procedures/Surgery

• TRUS with aspiration

• Transperineal ultrasound with aspiration

• Transurethral unroofing of prostate abscess

Pathologic Findings

• Purulent material will be expressed from prostate during surgical drainage procedure:

– Gram stain and culture of material will give causative agent, most commonly bacterial

DIFFERENTIAL DIAGNOSIS

• Clinically can be hard to distinguish from urinary tract infection (UTI), acute prostatitis, or any other lower UTI.

• Should have clinical suspicion, which can be confirmed with imaging.

TREATMENT

GENERAL MEASURES

• Initial treatment should focus on broad-spectrum antibiotics, IV hydration, and pain control.

• In the setting of acute urinary retention, a Foley catheter placement can be attempted.

– Occasionally the transurethral catheter may block drainage of an acutely inflamed prostate or cause bacteremia.

– In the setting of extreme discomfort or if the catheter is difficult to pass, a suprapubic punch cystostomy is preferred.

MEDICATION

First Line

• Broad-spectrum IV antibiotic therapy followed by directed therapy after causative organism determined by urine culture or Gram stain/culture of abscess fluid:

– 2nd-generation cephalosporins (cefoxitin, zinacef) or 3rd-generation cephalosporins (ceftriaxone, cefotaxime, ceftazidime)

– IV fluoroquinolones

– Clindamycin for additional anaerobic coverage is recommended initially

600–900 mg IV every 8 hr (q8h)

– After acute phase, continue oral antibiotic regimen based on cultures for up to 4 wk

Second Line

• Vancomycin for coverage of MRSA is suspected.

– Dose based on renal function

• Fungal infections may require 4–6 wk of systemic therapy in addition to drainage.

SURGERY/OTHER PROCEDURES

• Transurethral unroofing of prostate abscess

• Transperineal or transrectal needle aspiration with US guidance followed by urethral catheter drainage

– Can be performed using local anesthesia or sedation

– Higher risk of recurrence of abscess

• Open incision and drainage through a perineal approach

– Utilized in patients with penetration of the abscess through the capsule of the prostate or through the levator ani

– Allows placement of a drain

– Increased morbidity compared to open percutaneous or transurethral approaches

• Suprapubic cystotomy can be used as an adjunct for urinary diversion in patients with urinary retention

ADDITIONAL TREATMENT

Radiation Therapy

N/A

Additional Therapies

• Relates to predisposing conditions

• For patients with bladder outlet obstruction, therapy should be started to relieve obstruction, (ie, α-blockers or 5α-reductase inhibitors)

Complementary & Alternative Therapies

N/A

ONGOING CARE

PROGNOSIS

• Should recover fully once definitive therapy undertaken

• Although EPA is rare, a 25% mortality rate has been reported

COMPLICATIONS

• May progress to spontaneous fistulization into the urinary bladder, prostatic urethra, rectum, or perineum.

• Urosepsis, and possibly death if diagnosis not made in timely manner.

FOLLOW-UP

Patient Monitoring

• Supportive once definitive therapy performed

• Once acute events resolves, monitoring focuses on optimizing medical comorbidities and improving voiding symptoms.

• Author recommendation: CT or TRUS 4–6 wk after definitive therapy to confirm that no residual abscess remains

• Follow-up urine culture recommended

Patient Resources

N/A

REFERENCES

1. Granados EA, Riley G, Salvador J, et al. Prostatic abscess: Diagnosis and treatment. J Urol. 1992;148:80–82.

2. Ludwig M, Schroeder-Printzen I, Schiefer HG, et al. Diagnosis and therapeutic management of 18 patients with prostatic abscess. Urology. 1999;53(2):340–345.

3. Tai H. Emphysematous prostatic abscess: A case report and review of literature. J Infect. 2007;54:e51–e54.

ADDITIONAL READING

• Baker SD, Horger DC, Keane TE. Community-acquired methicillin-resistant Staphylococcus aureus prostatic abscess. Urology. 2004;64(4):808–810.

• Jang K, Lee DH, Lee SH, et al. Treatment of prostatic abscess: Case collection and comparison of treatment methods. Korean J Urol. 2012:53(12):860–864.

See Also (Topic, Algorithm, Media)

• Prostate, Abscess Image

• Prostatitis, Acute, Bacterial (NIH I)

• Urinary Tract Infection (UTI), Adult Male

• Urosepsis

CODES

ICD9

• 596.0 Bladder neck obstruction

• 601.0 Acute prostatitis

• 601.2 Abscess of prostate

ICD10

• N32.0 Bladder-neck obstruction

• N41.0 Acute prostatitis

• N41.2 Abscess of prostate

CLINICAL/SURGICAL PEARLS

• Prostate abscess is uncommon and thus often overlooked in the differential diagnosis.

• Suspect prostatic abscess in patients presenting with fever and persistent lower urinary tract symptoms that do not respond to antibiotics.

• A pelvic CT scan is generally the best test to evaluate for the possibility of a prostate abscess.

• A delay of antimicrobial therapy in the management of acute bacterial prostatitis can increase the risk of prostatic abscess.



If you find an error or have any questions, please email us at admin@doctorlib.org. Thank you!